The Effect of Erythropoietin on Neutrophil Production from Fetal Hematopoietic Progenitors

  • R. D. Christensen
Conference paper

Abstract

Erythropoietin (EPO) is a humoral regulator of erythropoiesis [1]. Its actions include stimulating proliferation and differentiation of committed erythroid progenitors [1], but it also affects certain nonerythroid cells [2–4]. For instance, megakaryocytes [2] and certain cells within developing GM clones [3, 4] respond to EPO. The latter cells, unlike erythroid and megakaryotic cells, respond to EPO by reducing, rather than increasing, formation of progeny [3, 4].

Keywords

Filtration Heparin Electrophoresis Anemia Neutropenia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Spivak JL (1986) The mechanism of action of erythropoietin. Int J Cell Cloning 4:139–142PubMedCrossRefGoogle Scholar
  2. 2.
    Berridge MV, Fraser JK, Carter JM, Lin F-K (1988) Effects of recombinant human erythropoietin on magakaryocytes and on platelet production in the rat. Blood 72:970–977PubMedGoogle Scholar
  3. 3.
    Van Zant G, Goldwasser E (1977) Simultaneous effects of erythropoietin and colony-stimulating factor on bone marrow cells. Science 198:733–735PubMedCrossRefGoogle Scholar
  4. 4.
    Migliaccio AR, Migliaccio G (1988) Human embryonic hemopoiesis:control mechanisms underlying progenitor differentiation in vitro. Develop Biol 125:127–134PubMedCrossRefGoogle Scholar
  5. 5.
    Holbrook ST, Christensen RD, Rothstein G (1988) Erythroid colonies derived from fetal blood display different growth patterns from those derived from adult marrow. Pediatr Res 24:605–608PubMedCrossRefGoogle Scholar
  6. 6.
    Iscove NN, Sieber F, Winterhalter KH (1974) Erythroid colony formation in cultures of mouse and human bone marrow. Analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J Cell Physiol 83:309–320PubMedCrossRefGoogle Scholar
  7. 7.
    Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM (1986) Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 2:1175–1177PubMedCrossRefGoogle Scholar
  8. 8.
    Eschback JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Eng J Med 316:73–78CrossRefGoogle Scholar
  9. 9.
    Brown MS, Garcia JF, Phibbs RH, Dallman PR (1984) Decreased response of plasma immunoreactive erythropoietin to “available oxygen” in anemia of prematurity. J Pediatr 105:793–798PubMedCrossRefGoogle Scholar
  10. 10.
    Shannon KM, Naylor GS, Torkildson JC, et al. (1987) Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med 317:728–733PubMedCrossRefGoogle Scholar
  11. 11.
    Rhondeau SM, Christensen RD, Ross MP, Rothstein G, Simmons MA (1988) Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the “anemia of prematurity”. J Pediatr 112:935–940PubMedCrossRefGoogle Scholar
  12. 12.
    Stone WJ, Graber SE, Krantz SB, Dessypris WN, O’Neil VL, Olson NJ, Pincus TP (1988) Treatment of the anemia of predialysis patients with recombinant human erythropoietin:a randomized, placebo-controlled trial. Am J Med Sci 296:171–179PubMedCrossRefGoogle Scholar
  13. 13.
    Bradley TR, Robinson W, Metcalf D (1967) Colony production in vitro by normal, polycythemic, and anaemic bone marrow. Nature 214:511PubMedCrossRefGoogle Scholar
  14. 14.
    Koenig JM, Christensen RD (1989) Neutropenia and thrombocytopenia in infants with Rh hemolytic disease. J Pediatr 114:625–631PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • R. D. Christensen

There are no affiliations available

Personalised recommendations